1 Market Overview
1.1 Biologics (Biosimilar) Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant Non-glycosylated Proteins
1.2.2 Recombinant Glycosylated Proteins
1.3 Market Analysis by Application
1.3.1 Oncology
1.3.2 Blood Disorders
1.3.3 Growth Hormonal Deficiency
1.3.4 Chronic and Autoimmune Disorders
1.3.5 Others
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Biologics (Biosimilar) Market Size Analysis from 2015 to 2028
1.6.1 Global Biologics (Biosimilar) Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Biologics (Biosimilar) Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Biologics (Biosimilar) Price Trends Analysis from 2015 to 2028
2 Global Biologics (Biosimilar) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biologics (Biosimilar) (Volume and Value) by Type
2.1.1 Global Biologics (Biosimilar) Consumption and Market Share by Type (2015-2020)
2.1.2 Global Biologics (Biosimilar) Revenue and Market Share by Type (2015-2020)
2.2 Global Biologics (Biosimilar) (Volume and Value) by Application
2.2.1 Global Biologics (Biosimilar) Consumption and Market Share by Application (2015-2020)
2.2.2 Global Biologics (Biosimilar) Revenue and Market Share by Application (2015-2020)
2.3 Global Biologics (Biosimilar) (Volume and Value) by Region
2.3.1 Global Biologics (Biosimilar) Consumption and Market Share by Region (2015-2020)
2.3.2 Global Biologics (Biosimilar) Revenue and Market Share by Region (2015-2020)
3 United States Biologics (Biosimilar) Market Analysis
3.1 United States Biologics (Biosimilar) Consumption and Value Analysis
3.2 United States Biologics (Biosimilar) Consumption Volume by Type
3.3 United States Biologics (Biosimilar) Consumption Structure by Application
4 Europe Biologics (Biosimilar) Market Analysis
4.1 Europe Biologics (Biosimilar) Consumption and Value Analysis
4.2 Europe Biologics (Biosimilar) Consumption Volume by Type
4.3 Europe Biologics (Biosimilar) Consumption Structure by Application
4.4 Europe Biologics (Biosimilar) Consumption by Top Countries
4.4.1 Germany Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.2 UK Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.3 France Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.4 Italy Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.5 Spain Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.6 Poland Biologics (Biosimilar) Consumption Volume from 2015 to 2020
4.4.7 Russia Biologics (Biosimilar) Consumption Volume from 2015 to 2020
5 China Biologics (Biosimilar) Market Analysis
5.1 China Biologics (Biosimilar) Consumption and Value Analysis
5.2 China Biologics (Biosimilar) Consumption Volume by Type
5.3 China Biologics (Biosimilar) Consumption Structure by Application
6 Japan Biologics (Biosimilar) Market Analysis
6.1 Japan Biologics (Biosimilar) Consumption and Value Analysis
6.2 Japan Biologics (Biosimilar) Consumption Volume by Type
6.3 Japan Biologics (Biosimilar) Consumption Structure by Application
7 Southeast Asia Biologics (Biosimilar) Market Analysis
7.1 Southeast Asia Biologics (Biosimilar) Consumption and Value Analysis
7.2 Southeast Asia Biologics (Biosimilar) Consumption Volume by Type
7.3 Southeast Asia Biologics (Biosimilar) Consumption Structure by Application
7.4 Southeast Asia Biologics (Biosimilar) Consumption by Top Countries
7.4.1 Indonesia Biologics (Biosimilar) Consumption Volume from 2015 to 2020
7.4.2 Thailand Biologics (Biosimilar) Consumption Volume from 2015 to 2020
7.4.3 Philippines Biologics (Biosimilar) Consumption Volume from 2015 to 2020
7.4.4 Malaysia Biologics (Biosimilar) Consumption Volume from 2015 to 2020
7.4.5 Singapore Biologics (Biosimilar) Consumption Volume from 2015 to 2020
7.4.6 Vietnam Biologics (Biosimilar) Consumption Volume from 2015 to 2020
8 India Biologics (Biosimilar) Market Analysis
8.1 India Biologics (Biosimilar) Consumption and Value Analysis
8.2 India Biologics (Biosimilar) Consumption Volume by Type
8.3 India Biologics (Biosimilar) Consumption Structure by Application
9 Brazil Biologics (Biosimilar) Market Analysis
9.1 Brazil Biologics (Biosimilar) Consumption and Value Analysis
9.2 Brazil Biologics (Biosimilar) Consumption Volume by Type
9.3 Brazil Biologics (Biosimilar) Consumption Structure by Application
10 GCC Countries Biologics (Biosimilar) Market Analysis
10.1 GCC Countries Biologics (Biosimilar) Consumption and Value Analysis
10.2 GCC Countries Biologics (Biosimilar) Consumption Volume by Type
10.3 GCC Countries Biologics (Biosimilar) Consumption Structure by Application
10.4 GCC Countries Biologics (Biosimilar) Consumption Volume by Major Countries
10.4.1 Saudi Arabia Biologics (Biosimilar) Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Biologics (Biosimilar) Consumption Volume from 2015 to 2020
10.4.3 Qatar Biologics (Biosimilar) Consumption Volume from 2015 to 2020
10.4.4 Bahrain Biologics (Biosimilar) Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Roche
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Roche Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.1.4 Roche Biologics (Biosimilar) Sales by Region
11.2 3sbio
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 3sbio Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.2.4 3sbio Biologics (Biosimilar) Sales by Region
11.3 Changchun High tech
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Changchun High tech Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.3.4 Changchun High tech Biologics (Biosimilar) Sales by Region
11.4 Sandoz
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Sandoz Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.4.4 Sandoz Biologics (Biosimilar) Sales by Region
11.5 Novartis
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Novartis Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.5.4 Novartis Biologics (Biosimilar) Sales by Region
11.6 Amgen
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Amgen Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.6.4 Amgen Biologics (Biosimilar) Sales by Region
11.7 AbbVie
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 AbbVie Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.7.4 AbbVie Biologics (Biosimilar) Sales by Region
11.8 Hospira
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Hospira Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.8.4 Hospira Biologics (Biosimilar) Sales by Region
11.9 Gelgen Biopharma
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Gelgen Biopharma Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.9.4 Gelgen Biopharma Biologics (Biosimilar) Sales by Region
11.10 Merck
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Merck Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.10.4 Merck Biologics (Biosimilar) Sales by Region
11.11 Pfizer
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Pfizer Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.11.4 Pfizer Biologics (Biosimilar) Sales by Region
11.12 Novo Nordisk
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Novo Nordisk Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.12.4 Novo Nordisk Biologics (Biosimilar) Sales by Region
11.13 Johnson & Johnson
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Johnson & Johnson Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.13.4 Johnson & Johnson Biologics (Biosimilar) Sales by Region
11.14 Sanofi
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 Sanofi Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.14.4 Sanofi Biologics (Biosimilar) Sales by Region
11.15 Biotech Pharma
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Biotech Pharma Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.15.4 Biotech Pharma Biologics (Biosimilar) Sales by Region
11.16 Lilly
11.16.1 Business Overview
11.16.2 Products Analysis
11.16.3 Lilly Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.16.4 Lilly Biologics (Biosimilar) Sales by Region
11.17 Mylan
11.17.1 Business Overview
11.17.2 Products Analysis
11.17.3 Mylan Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.17.4 Mylan Biologics (Biosimilar) Sales by Region
11.18 CP Guojian Pharmacy
11.18.1 Business Overview
11.18.2 Products Analysis
11.18.3 CP Guojian Pharmacy Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.18.4 CP Guojian Pharmacy Biologics (Biosimilar) Sales by Region
11.19 Teva
11.19.1 Business Overview
11.19.2 Products Analysis
11.19.3 Teva Biologics (Biosimilar) Sales, Price, Revenue, Gross Margin
11.19.4 Teva Biologics (Biosimilar) Sales by Region
13 Global Biologics (Biosimilar) Market Forecast (2020-2028)
13.1 Global Biologics (Biosimilar) Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Biologics (Biosimilar) Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Biologics (Biosimilar) Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Biologics (Biosimilar) Price and Trend Forecast (2020-2028)
13.2 Global Biologics (Biosimilar) Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Biologics (Biosimilar) Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Biologics (Biosimilar) Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Biologics (Biosimilar) Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Biologics (Biosimilar) Consumption Forecast by Type (2020-2028)
13.3.2 Global Biologics (Biosimilar) Revenue Forecast by Type (2020-2028)
13.3.3 Global Biologics (Biosimilar) Price Forecast by Type (2020-2028)
13.4 Global Biologics (Biosimilar) Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
